Mirhafez Seyed Reza, Tajfard Mohammad, Avan Amir, Pasdar Alireza, Nedaeinia Reza, Aghasizade Malihe, Davari Hafezeh, Manian Mostafa, Mahdizadeh Adeleh, Meshkat Zahra, Movahedi Ali, Amini Nahid Ghaed, Eskandari Nahid, Salehi Rasoul, Ferns Gordon A, Ghayour-Mobarhan Majid
Department of Basic Medical Sciences, Neyshabur University of Medical Sciences, Neyshabur, Iran; Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Department of Modern Sciences and Technologies, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Clin Biochem. 2016 Jul;49(10-11):750-5. doi: 10.1016/j.clinbiochem.2016.03.009. Epub 2016 Apr 2.
Hypertriglyceridemia is an established risk factor for coronary-heart-disease. Inflammatory cytokines are known to be important mediators of atherogenesis; however, the relationship between the concentrations of specific inflammatory cytokines and the presence of hypertriglyceridemia has not been well established. The purpose of this study was to investigate the relationship between the serum levels of several pro- and anti-inflammatory cytokines and the presence of hypertriglyceridemia.
Four hundred and eighty-four subjects with/without established hypertriglyceridemia were recruited. Anthropometric parameters and biochemical analysis (including a full fasting lipid profile) were determined. The serum levels of several cytokines and growth factors including IL-1α, IL-1β, IL-2, IL-4, IL-6, IL-8, IL-10, TNF-α, MCP-1, IFN-γ, EGF, and VEGF were measured followed by univariate and multivariate analyses.
Individuals with hypertriglyceridemia had a significantly higher body mass index, total-cholesterol and triglyceride, compared to the group without hypertriglyceridemia. Serum levels of MCP-1, TNF-α and IL-8 were significantly higher in subjects with hypertriglyceridemia [e.g., IL-8 from 7.8ng/L (95% CI: 4.6-18.9) versus 5.7ng/L (95% CI: 3.6-11.9), P<0.05]. The multivariate analysis showed that the increased serum concentration of TNF-α was independently associated with high-density lipoprotein cholesterol (HDL-C), while the serum levels of IL-8 and MCP-1 were associated with hypertriglyceridemia.
Subjects with serum triglycerides of ≥2.25mmol/L had an altered cytokine-profile, particularly with respect to serum IL-8, MCP-1 and TNF-α, which might partially account for its adverse clinical-consequences. Further-investigations in a large multi-center setting are warranted to unravel the potential functional-importance of these cytokines in individuals with hypertriglyceridemia.
高甘油三酯血症是冠心病的既定危险因素。已知炎性细胞因子是动脉粥样硬化形成的重要介质;然而,特定炎性细胞因子浓度与高甘油三酯血症之间的关系尚未完全明确。本研究的目的是探讨几种促炎和抗炎细胞因子的血清水平与高甘油三酯血症之间的关系。
招募了484名有/无确诊高甘油三酯血症的受试者。测定人体测量参数和生化分析指标(包括完整的空腹血脂谱)。检测几种细胞因子和生长因子的血清水平,包括白细胞介素-1α(IL-1α)、白细胞介素-1β(IL-1β)、白细胞介素-2(IL-2)、白细胞介素-4(IL-4)、白细胞介素-6(IL-6)、白细胞介素-8(IL-8)、白细胞介素-10(IL-10)、肿瘤坏死因子-α(TNF-α)、单核细胞趋化蛋白-1(MCP-1)、干扰素-γ(IFN-γ)、表皮生长因子(EGF)和血管内皮生长因子(VEGF),随后进行单因素和多因素分析。
与无高甘油三酯血症的组相比,高甘油三酯血症患者的体重指数、总胆固醇和甘油三酯显著更高。高甘油三酯血症患者的MCP-1、TNF-α和IL-8血清水平显著更高[例如,IL-8从7.8ng/L(95%置信区间:4.6 - 18.9)升至5.7ng/L(95%置信区间:3.6 - 11.9),P<0.05]。多因素分析表明,TNF-α血清浓度升高与高密度脂蛋白胆固醇(HDL-C)独立相关,而IL-8和MCP-1的血清水平与高甘油三酯血症相关。
血清甘油三酯≥2.25mmol/L的受试者细胞因子谱发生改变,尤其是血清IL-8、MCP-1和TNF-α,这可能部分解释了其不良临床后果。有必要在大型多中心环境中进行进一步研究,以阐明这些细胞因子在高甘油三酯血症个体中的潜在功能重要性。